Scope Fluidics S.A. (WSE:SCP)
116.60
-0.60 (-0.51%)
May 27, 2026, 12:33 PM CET
Scope Fluidics Revenue
Scope Fluidics had revenue of 27.00K PLN in the quarter ending March 31, 2026, with 17.39% growth. This brings the company's revenue in the last twelve months to 104.00K, down -11.11% year-over-year. In the year 2025, Scope Fluidics had annual revenue of 100.00K, down -23.66%.
Revenue (ttm)
104.00K
Revenue Growth
-11.11%
P/S Ratio
3,570.40
Revenue / Employee
n/a
Employees
132
Market Cap
371.32M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 100.00K | -31.00K | -23.66% |
| Dec 31, 2024 | 131.00K | -385.00K | -74.61% |
| Dec 31, 2023 | 516.00K | 112.00K | 27.72% |
| Dec 31, 2022 | 404.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.83B |
| Diagnostyka | 2.42B |
| Centrum Medyczne ENEL-MED | 854.27M |
| Synektik Spólka Akcyjna | 706.45M |
| BIOTON | 282.52M |
| Celon Pharma | 226.35M |
| Ryvu Therapeutics | 88.38M |
| Medicalgorithmics | 30.99M |